Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ablynx
Biotech
Sanofi, after $8B outlay, sees M&A strategy deliver 2 more duds
The French drugmaker removed Ablynx and Principia Biopharma molecules from its pipeline after getting a look at clinical data.
Nick Paul Taylor
Apr 27, 2023 7:41am
SynOx taps chief medical, tech officers week after CEO hire
Aug 3, 2021 12:44pm
Hoping to win where Novartis failed, Inhibrx files for $75M IPO
Jun 4, 2019 9:26am
Confo raises €30M series A round to target hard-to-drug GPCRs
May 7, 2019 7:00am
Chimerix CEO replaced by a trio of officers—Chutes & Ladders
Feb 8, 2019 9:00am
A universal flu vaccine from llamas?
Nov 5, 2018 2:28pm